What happens when ocular melanoma spreads to the liver?

Uveal melanoma, the most common primary intraocular tumor,1–4 has an associated approximate 40% risk of metastasizing to the liver within 10 years of diagnosis of the primary tumor. Hepatic metastases, which occur in 95% of patients with metastatic uveal melanoma,5 result in death in almost all cases.

Where does uveal melanoma spread to?

While many patients treated for uveal melanoma are free from the disease following treatment, about half will develop metastatic disease within 15 years of their original diagnosis. In 90% of these cases the melanoma spreads to the liver; less frequently it spreads to the lungs, bones, and brain.

What is the prognosis for melanoma that has spread to the liver?

Life expectancy of the malignant melanoma with gastrointestinal tract or liver metastases is virtually 6–9 months. This ratio is exceeding 46–48 months after radical surgical interventions performed [17–19].

How often does melanoma spread to the liver?

Background Metastases to the liver are diagnosed in 10% to 20% of patients with American Joint Committee on Cancer stage IV melanoma.

When does melanoma spread to the liver?

Melanoma usually spreads through the body’s blood vessels to the liver. Liver metastases are sometimes present when the original (primary) cancer is diagnosed, or it may occur months or years after the primary tumor is removed. After the lymph nodes, the liver is the most common site of metastatic spread.

Can melanoma cause liver damage?

Metastatic melanoma (also known as stage IV) is a general term for the spreading of cancer beyond its original site. The liver is the most common site of metastasis in ocular melanoma. Among those who develop metastatic disease, 90% of patients develop liver disease.

How often does melanoma metastasize to the liver?

Background Metastases to the liver are diagnosed in 10% to 20% of patients with American Joint Committee on Cancer stage IV melanoma. Surgical resection has not been generally accepted as a therapeutic option, as most patients will have other sites of disease that limit their survival to a median of only 4 to 6 months.

Can melanoma in liver be cured?

In most cases, cancer that has spread to the liver is not curable. However, the treatments discussed above may help shrink tumors, improve life expectancy, and relieve symptoms.

What are the symptoms of melanoma in the liver?

If melanoma spreads to the liver, specific symptoms may include:

• Loss of appetite.
• Fatigue or lethargy.
• Jaundice (yellowing of the skin or whites of eyes)
• Swelling in the abdomen or legs.
• Itchiness.

How long does it take for melanoma to spread to organs?

How fast does melanoma spread and grow to local lymph nodes and other organs? “Melanoma can grow extremely quickly and can become life-threatening in as little as six weeks,” noted Dr. Duncanson. “If left untreated, melanoma begins to spread, advancing its stage and worsening the prognosis.”

Can melanoma spread to liver?

Where does melanoma most often metastasize?

Skin and subcutaneous tissue are the most common sites of melanoma metastasis.

What is the pathophysiology of uveal melanoma?

One unique characteristic of uveal melanoma is that the majority of metastases first develop in the liver. The liver is highly specialized in development of immune tolerance to food-derived antigens and consequently serves a unique function in the immune system.

What is the prognosis of uveal melanoma without BAP1 protein?

Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Br J Cancer 2014;111:1373-80.

Is there a cure for metastatic uveal melanoma?

Unfortunately, metastatic uveal melanoma is unresponsive to this approach, thus there is an unmet need to improve the treatment of metastatic uveal melanoma. One unique characteristic of uveal melanoma is that the majority of metastases first develop in the liver.

What is the difference between CXCR4 and CCR7 in uveal melanoma?

Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance. Invest Ophthalmol Vis Sci 2013;54:7354-61.